Recent Comments
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (23,673)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,656)
- New treatment paradigm for C. Diff colitis (16,057)
- The Healthcare Channel hits 10 (15,520)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,307)
- How the FDA regulates compounding pharmacies (15,136)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,984)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (10,966)
- The new CDC guidelines for prescribing opioid pain pills (10,433)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,297)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Oncology
Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
The transcript is found here May 19, 2023- by Steven E. Greer, MD
Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies
July 12, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology
Leave a comment
The Who’s Teen Cancer Lounge at Sloan Kettering opens
March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge
Posted in Memorial Sloan-Kettering, Oncology
Leave a comment
Meatless diets are a bad idea
April 29, 2024- by Steven E. Greer, MD
Steven E. Greer MD: A discussion with Bill O’Reilly about radiation risks
April 1, 2011- A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.
Posted in - Policy, Congress, NYU, Ohio State, Oncology
Leave a comment
Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity
September 1, 2023- by Sucharit Bhakdi, MD et al
Did the COVID vaccines change the human genome?
May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology
Leave a comment
Daily aspirin once again proves to be of no use and also deadly
Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin.
The Daltrey Townshend teenage and young adult cancer center at UCLA
May 4, 2014- Interviewed by Steven E. Greer More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage
Posted in - Opinion, Oncology, Rehab, UCLA
Leave a comment
Crystalloid “Balanced Lactated Ringer’s” IV solution is safer to the kidneys
March 1, 2018- Interviewed by Steven E. Greer, MD We interviewed Vanderbilt’s Todd Rice, MD about his NEJM papers that showed crystalloid, or
Posted in - NEJM, Cardiac surgery, Cardiology, Emergency medicine, General surgery, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Pediatrics, Plastic surgery, Sports medicine, Trauma Surgery, Urology, Vanderbilt, Vascular Surgery
Leave a comment
Interview with Simon Townshend about the Daltrey/Townshend Teen Cancer Program
The Daltrey Townshend teenage and young adult cancer center at UCLA
Posted in Oncology, UCLA
Leave a comment
The new CDC guidelines for prescribing opioid pain pills
June 1, 2016- Interviewed by Steven E. Greer, MD Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded
TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it
March 23, 2019- Updated April 14, 2020 by Steven Greer Nobody has
Posted in - Pharma, Cardiology, CDC, FDA, Oncology
Comments Off on TV Quack Dr. David Agus still likes daily aspirin despite heart guidelines dropping it
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,
Paul Richardson, MD: Current Therapies for Multiple Myeloma
December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
BRAF and MEK combos for melanoma
Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment